Skip to main content
Clinical Trials/NCT02526862
NCT02526862
Completed
Phase 4

Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation. Randomized Clinical Trial

B. Braun Medical SA1 site in 1 country152 target enrollmentFebruary 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Respiratory Failure
Sponsor
B. Braun Medical SA
Enrollment
152
Locations
1
Primary Endpoint
Incidence of PU for each group (mean, standard deviation and quartiles)
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study aims to test direct application of the Non-Invasive Mechanical Ventilation -NIVM- mask or interface as the most efficient intervention to prevent Pressure Ulcers (PU), compared with other three usual preventive measures which consist in the use of three different medical devices.

Detailed Description

Non-Invasive Mechanical Ventilation (NIVM) has turned into a standard in the care of patients with acute respiratory failure. Defined as a support modality to the patient's spontaneous ventilation, it does not use invasive techniques to ventilate, working as an external device named interface or mask, avoiding so the complications associated to the invasive ventilation. NIVM had been restricted to ICU and Pneumology services, but in the last years it has been extended to ER with good results and it is being also used in the pre-hospital attention and in the home care of chronic patient. Often, the preferred interface is the oronasal, worst tolerated but associated to best treatment of the acute pathology. In most cases to avoid air leaks, its proper placement generates high pressure on the skin, being able to harm patient's tissues, so that this therapy as intervention for the acute patient has pressure ulcers -PU- as main iatrogenic effect - although 95% of the PU are considered as preventable-. To diminish the pressure of the mask on the points of the face, nurses protect the most exposed zones with dressings of hydrogel-foam, polyurethane and/or hyperoxygenated fatty acids, trying to prevent PU. Reviewed studies present a big variability in these practices as well as high dispersion of the results achieved. Preventive measures are different and even none, as applying the mask or the interface directly could be the most effective treatment in the prevention of PU, avoiding not justified increase of fungible and other resources consumption. The aim of this study is to test direct application of the mask or interface, as the most efficient intervention, compared with other three usual preventive measures which consist in the use of three different medical devices: autoadhesive polyurethane dressing (Allevyn Thin®), semi-permeable hydrogel-foams adhesive dressing (Askina Transorbent Border®) or hyperoxygenated fatty acids (Linovera®)

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
August 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Peña Otero

Nurse, Master of Science

Hospital General Universitario Gregorio Marañon

Eligibility Criteria

Inclusion Criteria

  • Adults (≥18 years).
  • Not tissue injury in face.
  • Not structural deformation of the facial anatomy.

Exclusion Criteria

  • Rejects Informed Consent

Outcomes

Primary Outcomes

Incidence of PU for each group (mean, standard deviation and quartiles)

Time Frame: First 24 hours after the withdrawal of the treatment

Compare the efficacy of the preventive treatments A, B, C and D - previously described-(meaning by efficacy the no occurrence of PU). For definition of PU investigators use the one of the "National Group for the Study and Advice in Pressure Ulcer and Chronic Wounds" (GNEAUPP)

Secondary Outcomes

  • Efficiency of preventive measures for PU related to NIVM, by registering incidence and resources invested -time in hours and consumables in euros- (mean, standard deviation and quartiles for each group)(24 hours after the withdrawal of the treatment)
  • Incidence of total NIVM related PU, by observation registers.(24 hours after the withdrawal of the treatment)

Study Sites (1)

Loading locations...

Similar Trials